ICD-10 Specific code F42.9: Obsessive-compulsive disorder, unspecified
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Obsessive-compulsive disorder, unspecified |
French
|
Trouble obsessionnel-compulsif, sans précision |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Mental and behavioural disorders | |
| 2 | F40-F48 | Neurotic, stress-related and somatoform disorders | |
| 3 | F42 | Obsessive-compulsive disorder | |
| 4 | F42.9 | Obsessive-compulsive disorder, unspecified |
Indicated medicines
| Active Ingredient |
|---|
|
Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity. The inhibition of 5-HT re-uptake is the only likely mechanism of action explaining the pharmacological and clinical effects of escitalopram. |
|
The mechanism of action of fluvoxamine is thought to be related to selective serotonin re-uptake inhibition in brain neurones. There is minimum interference with noradrenergic processes. Receptor binding studies have demonstrated that fluvoxamine has negligible binding capacity to alpha adrenergic, beta adrenergic, histaminergic, muscarine cholinergic, dopaminergic or serotonergic receptors. |
|
Sertraline is a potent and specific inhibitor of neuronal serotonin (5-HT) uptake in vitro, which results in the potentiation of the effects of 5-HT in animals. It has only very weak effects on norepinephrine and dopamine neuronal reuptake. |